STEMBIORX
Live / Registered — Registered (as of 27 Apr 2021)
What this means for you
Registered since 27 Apr 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 27 Apr 2027, and its filing window is open now).
Record
- Serial number
- 88975247
- Registration number
- 6336732
- Mark type
- Word mark
- Filed
- 06 Aug 2018
- Published for opposition
- 01 Jan 2019
- Registered
- 27 Apr 2021
- Next maintenance filing
- §8 declaration of use, due by 27 Apr 2027 (grace period to 27 Oct 2027)
- Attorney of record
- Michael Bell
Goods and services
- Class 005 — Pharmaceuticals: Medicaments for treating pain, nausea, anxiety, and fatigue; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Nausea treatment preparations; Pharmaceutical preparation for skin care; Preparation for the relief of pain
Owner
- Stembiorx, Inc., Irvine, CA, US
- Stembiorx, Inc., Irvine, CA, US
- Stembiorx, Inc., Irvine, CA, US
Prosecution history
- 27 Apr 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 Apr 2021 — REGISTERED-PRINCIPAL REGISTER
- 26 Mar 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Mar 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Mar 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Apr 2019 — USE AMENDMENT FILED
- 03 May 2019 — DIVISIONAL PROCESSING COMPLETE
- 05 Apr 2019 — DIVISIONAL REQUEST RECEIVED
- 26 Apr 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Apr 2019 — TEAS REQUEST TO DIVIDE RECEIVED
- 05 Apr 2019 — TEAS STATEMENT OF USE RECEIVED
- 26 Feb 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Jan 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Jan 2019 — PUBLISHED FOR OPPOSITION
- 12 Dec 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED